Legal Opinion
Lupin Ltd. v. Salix Pharmaceuticals, Inc.
District Court, S.D. New York
Decided September 10, 2024No. 1:22-cv-07656Unknown
1Opinion
sages USDC SDNY NORTON ROSE FULBRIGHT September 6, 2024 || DOCUMENT Norton Rose Fulbright US LLP ELECTRONICALLY FILED 1301 Avenue of the Americas BY ECF DOC #: New York, New York 10019-6022 DATE FILED: 9/10/2024 United States of America Direct line +1 212 318 3108 The Hon. Robert W. Lehrburger robin.adelstein @ nortonrosefulbright.com Daniel Patrick Moynihan U.S. Courthouse 500 Pearl Street Tel +1 212 318 3000 New York, New York 10007 Fax +1 212 318 3400 Re: Lupin Ltd. v. Salix Pharma., Inc., et al., No. 1:22-cv-07656-JHR-RWL Dear Judge Lehrburger: We represent Defendant and…
2Cases cited3 opinions
- Lugosch v. Pyramid Co. of OnondagaCourt of Appeals for the Second Circuit · 2006
- In Re Gabapentin Patent LitigationDistrict Court, D. New Jersey · 2004
- Appleton v. Food & Drug AdministrationDistrict Court, District of Columbia · 2006